(Q82771002)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22134716%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Dual inhibition of Jak2 and STAT5 enhances killing of myeloproliferative neoplasia cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22134716%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

M Bar-Natan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22134716%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

E A Nelson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22134716%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

S R Walker

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22134716%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Y Kuang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22134716%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

R J Distel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22134716%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

D A Frank

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22134716%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

2 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22134716%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22134716%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22134716%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22134716%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

1407-1410

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22134716%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2011.338

17 January 2020

exact match

0 references

cites work

Myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.338

7 January 2021

Oncogenic mechanisms in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.338

7 January 2021

Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.338

7 January 2021

TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.338

7 January 2021

Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.338

7 January 2021

MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.338

7 January 2021

Phospho-STAT5 and phospho-Akt expression in chronic myeloproliferative neoplasms.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.338

7 January 2021

STAT5 activation is critical for the transformation mediated by myeloproliferative disorder-associated JAK2 V617F mutant

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.338

7 January 2021

The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.338

7 January 2021

Kinome profiling in pediatric brain tumors as a new approach for target discovery

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.338

7 January 2021

Janus kinases: components of multiple signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.338

7 January 2021

Effects of the JAK2 inhibitor, AZ960, on Pim/BAD/BCL-xL survival signaling in the human JAK2 V617F cell line SET-2.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.338

7 January 2021

FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD-specific STAT5 activation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.338

7 January 2021